Grifols KIRO® Oncology is the next-generation system for compounding of sterile preparations of oncology drugs, including chemotherapy and biologicals. Grifols is a global healthcare company with more than 75 years of experience and a record of maintaining excellent quality and safety standards in all of its manufacturing processes. Grifols is therefore uniquely qualified to help make compounding safer. Grifols i.v.TOOLS is a set of products, technologies, processes, management tools, and related services designed to enhance quality, safety, and efficiency in compounding. Grifols i.v.TOOLS products are designed to improve institutional compliance with guidelines and regulations. In addition, we provide customized services and consultation on all aspects of compounding. This includes environmental design and monitoring, operational analysis and workflow, process implementation, and regulatory compliance. Grifols’ high standards of quality and excellent service make a decisive contribution to minimizing the risks associated with compounding of sterile preparations.
This post is related to:Automation & Robotics